Charlotte's Web Holdings

  • Ticker:CSE:CWEB
  • Ticker 2:OTCMKTS:CWBHF
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Adrienne Elsner
  • Founded:2013
Categories:
About Us

Charlotte's Web (CSE:CWEB) is the #1 player in the US CBD market, by SKU range, retail outlets selling their products, and general brand recognition. The brand benefitted greatly from the story of young Charlotte Fiji – who had a very severe case of epilepsy namely the Dravet syndrome – and was able to be seizure-free on the propriety hemp-derived CBD trains that the Stanley Brothers produced.

CWEB is a vertically-integrated company, who recently increased the total acres of hemp planted for 2019 to 862, an 187% increase from 300 acres planted in 2018.

During Q2 in 2019, Charlotte's Web introduced a new range of hemp extract infused CBD gummies in three flavors, and a new twelve SKU pet product line to support specific health functions – Calming, Hips & Joints and Cognition.

The company has also signed two distribution partners for its pet line; Pacific Pet in California, one of the largest distributors of pet food and pet products on the west coast, servicing 1,000 independent pet stores in California, Arizona, Nevada, and Hawaii; and "Pet Food Experts", servicing over 4,000 retailers in 33 states out of five distribution centers located in Rhode Island, Pennsylvania, Illinois, Washington and Colorado.

More From Charlotte's Web Holdings...
Knock Out – CWEB Punches Through with CBD Gummies and Strong Q1 Results
Charlotte's Web Releases New CBD Gummy Range
Charlotte's Web Q1 Results Out: Up 66% From Previous Year
Lift Off – CWEB, Cresco and Trulieve Rocket Ahead with Q1 2019 Results
Charlotte's Web Holdings Reports 2019 Q1 Earnings
Charlotte's Web Receives Approval to Trade on TSX
Best Buds: CBD Supplements For Pets
Weed in Wellness: CBD in Nutraceuticals
Hemp Stocks: The Battle of the Green Giants
Reefer Gladness – Cronos, CWEB, and CVSI Publish Eye Catching Q1 2019 Results
Load More Results
Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.

Management
Deanie Elsner
Chief Executive Officer
Deanie Elsner is the former President of U.S. Snacks division at Kellogg Company, and has more than 25 years of diverse consumer packaged goods (“CPG”) experience across both business and marketing leadership roles in domestic and international markets. Prior to joining the Kellogg Company, she served more than 20 years in various leadership roles at the Kraft Foods Company including Executive Vice President and Chief Marketing Officer, where she was named by Forbes as one of the 50 Most Influential Global CMOs. Ms. Elsner is credited for successfully launching over $650MM Net Revenue in innovation including, MiO Water Enhancers, Gevalia Café, Keurig compatible Coffee Pods and specialty beverages. Her experience also includes sales roles at Procter & Gamble and Johnson & Johnson.
Russell Hammer
Chief Financial Officer & Executive Vice President
Russell Hammer has extensive financial leadership experience in domestic and international markets, including the retail, e-commerce, and technology sectors. Hammer has served as Chief Financial Officer for leading multibillion dollar multinational companies including Caleres Brands, Orbitz and Crocs. He was also previously employed as the Chief Financial Officer of several Motorola business units and Chief Audit Officer.
Stephen Lermer
Chief Operating Officer
Stephen Lermer joined Charlotte's Web as the company’s Chief Operating Officer in January 2019, overseeing all aspects of manufacturing, supply chain, research & development, legal and regulatory affairs, quality assurance and control, engineering, cultivation and operations management functions. He has over 38 years of experience overseeing start-up, mid and large-scale global pharmaceutical, cosmetic and consumer-packaged goods (“CPG”) operations, product development and commercialization, and manufacturing and distribution. Prior to joining Charlotte’s Web he was employed in the pharmaceutical industry, where he held senior leadership and executive positions at DuPont, Johnson & Johnson, Burroughs Wellcome (now GlaxoSmithKline), Rhone Poulenc (now Sanofi), Orion Oyj and Akela Pharma.